20 likes | 32 Views
The Global Epilepsy Devices Market was is likely to reach $1157.58 million by 2028, growing at a CAGR of 8.16% during the forecast period 2022-2028. Read More.
E N D
Global Epilepsy Devices Market to Grow at 8.16% CAGR by 2028 TritonMarketResearchpresentstheGlobal Epilepsy Devices MarketreportsectionedbyDeviceType(TraditionalDevices,WearableDevices[Watches,Bracelets,CameraDevices,MattressDevices,Anti-suffocationPillows,OtherWearableDevices],ImplantableDevices),Application(VagusNerveStimulation,DeepBrainStimulation[MovementDisorders,Epilepsy],Accelerometer,ResponsiveNeurostimulation),DetectionandPredictionDeviceType(Electroencephalogram,IntracranialEEG,SurfaceElectromyography,Electrocardiography,VideoDetectionSystems,ElectrodermalActivity,ImplantedAdvisorySystems,OtherDetectionandPredictionDeviceTypes),End-user(Hospitals&Clinics,NeurologyCenters,HomecareSettings,OtherEnd-users),andRegionalOutlook(NorthAmerica,Europe,MiddleEastandAfrica,LatinAmerica,Asia-Pacific). ThereportfurtherdiscussestheMarketSummary,IndustryOutlook,ImpactofCOVID-19,KeyInsights,Porter’sFiveForcesAnalysis,KeyBuyingImpactAnalysis,MarketAttractivenessIndex,VendorScorecard,IndustryComponents,RegulatoryFramework,KeyMarketStrategies,Drivers,Challenges,Opportunities,CompetitiveLandscape,ResearchMethodology&Scope,GlobalMarketSize,Forecasts&Analysis(2022-2028). RequestFreeSampleReport: https://www.tritonmarketresearch.com/reports/epilepsy-devices-market#request-free-sample ThereportbyTritonMarketResearchhighlightsthattheglobalepilepsydevicesmarketisestimatedtowitnessgrowthataCAGRof8.16%overtheforecastperiod2022-2028. Epilepsydevicesrefertotheequipmentthatdiagnosesrecurrentseizuresinvolvinginstancesofinvoluntarymovementoftheentirebodyorcertainpartsofthebody.
Thepoint-of-caresystemshelpintheearlyidentification,diagnosis,andtreatmentofepilepsytoachieveapositiveoutcome.Ifthebeginningofaseizure(prognosis)canbeidentifiedorpre-treatedusingpoint-of-care(POC)systems,thenepilepsycanbemanagedwellwhilereducingfear.Thepoint-of-caresystemshelpintheearlyidentification,diagnosis,andtreatmentofepilepsytoachieveapositiveoutcome.Ifthebeginningofaseizure(prognosis)canbeidentifiedorpre-treatedusingpoint-of-care(POC)systems,thenepilepsycanbemanagedwellwhilereducingfear. Furthermore,governmentshaveoverhauledthehealthsystemstoenhancehealthcareservices.Theyhavealsostarteddevelopinglegislativeandregulatoryframeworks,funding,recognizingexistingcareandresourcegaps,andstrengtheningpublic-privatepartnerships.Thus,combating epilepsythroughearlydetectionanddiagnosiscangeneratevariousopportunitiesfortheepilepsydevicesmarket. However,theunawarenessofepilepsyamongthepublicandtheinadequatenumberofneurologyspecialistsinthehealthcaresystemcannegativelyimpactthedevelopmentoftheepilepsydevicesmarket. Globally,Asia-Pacificisanticipatedtobethefastest-growingregionintheepilepsydevicesmarket.Theregion’sgrowthisduetothehighprevalenceofepilepsyandthegrowinggeriatricpopulationintheregion.Additionally,theregionisattractingkeyglobalplayersbyofferingtraining&researchopportunitiesandfavorableinitiativesthroughtheNationalMinistriesofHealth.Theseinitiativeswillidentifyneedsandpromoteeducation,research,training,prevention,treatment,andcareservices.Thus,theaforementionedfactorsareanticipatedtodrivetheregion’smarketgrowththroughouttheforecastingperiod. TheprominentplayersintheepilepsydevicesmarketincludeLivaNovaPlc,NatusMedicalIncorporated,CadwellIndustriesInc,NihonKohdenCorporation,CompumedicsLimited,MedtronicPlc,BostonScientificCorporation,EmpaticaInc,KoninklijkePhilipsNV,NeuroPaceInc,DrägerwerkAG&CoKGaA,ShenzhenMindrayBio-MedicalElectronicsCoLtd,andNeurosoft. Thecompaniesinthemarketarefocusedondevelopinglessexpensiveplatformstomakethedevicesaffordable.Theyarealsoattemptingtodevelopnewtechnologiesthatwillgiveanedgetotheirproducts.Forexample,severalmanufacturersareintegratingmachinelearningandartificialintelligencetoimproveproductdifferentiation.Thus,thedegreeofcompetitionintheepilepsydevicesmarketismoderate. ContactUs:sales@tritonmarketresearch.comPhone:+447441911839